Tag Archives: European Union

European Pharma 1981-2011: Survival of the Fittest?

This month sees Pharmaceutical Executive magazine reach its 30th birthday. In line with that milestone, Reflector assesses what the last three decades have meant for European pharma — and shows how the game has changed beyond recognition. Thirty years is a long time in any industry. The coalmining industry, the market for air travel, or telecommunications [...]
Posted in Emerging Markets, Europe, Global, Guest Blog, IP, Pharm Exec Magazine, R&D, Regulatory, healthcare, leadership | Also tagged , , , , , | Leave a comment

Europe: Into the HTA Fray

Reflector finds some surprising common ground in what should be two very different HTA reports. Just like with buses, you wait for ages for an international review of health technology assessment to come along, then two turn up at once.
Posted in Europe, Global, Guest Blog, Regulatory, healthcare, pricing | Also tagged , , , , | Leave a comment

Seeing Through the EU Transparency Directive

Reflector outlines why the EU’s so-called “transparency directive” has not set the industry on fire. For such a big subject, it is receiving little public attention. No matter how much pharma executives eulogise the heady prospects for personalised medicine or the protean potential of pharmacogenomics, everything all comes down, at the end of the day, to money. [...]
Posted in Europe, Global, Guest Blog, Regulatory, pricing | Also tagged , , | Leave a comment

Is Hungary Hungry Enough for Pharma?

Hungary has taken over the chair of the EU Council, but European pharma is unlikely to gain much from its surface enthusiam, writes Reflector. A new, young, and supposedly business-friendly democracy has swung into European action this month. Hungary, one of the most recent countries to join the European Union, took over the chair of the [...]
Posted in Europe, Global, Guest Blog, Regulatory, Strategy | Also tagged , , , | Leave a comment

EU Health Commissioner Emerges from the Dark

After a period of near invisibility, the EU’s health commissioner John Dalli has begun to make some higher profile appearance. Pharm Exec’s Europe correspondent Reflector assesses how these have been received by the pharma industry. Just before the holiday break, John Dalli, the European Union’s unobtrusive commissioner for health, has at last emerged from obscurity to [...]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , | 1 Comment